NCT01488929 · Interventional trial
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
Overall registry status Completed
Phase 2
Conditions Cognitive Dysfunction, Negative Symptoms, Schizophrenia
Delaware Valley sites
- CRI Worldwide, LLC · Marlton, NJ · Burlington County
First posted
Registry updated
Added to the directory